Guidance for the prevention and treatment of venous thromboembolism in cancer patients
Ahmad Awada(Centre Hospitalier Interrégional Edith Cavell), Peter Verhamme(KU Leuven), Christof Vulsteke(University of Antwerp), Kristin Jochmans(Palmetto Hematology Oncology), Jeroen Mebis(Jessa Hospital), Jean‐Michel Hougardy(Erasmus Hospital), Jean‐François Baurain(Cliniques Universitaires Saint-Luc), Michiel Strijbos, Pierre Hainaut(Université Grenoble Alpes), Paul M. Clément(Universitair Ziekenhuis Leuven), Stéphane Holbrechts(CHU Ambroise Paré), Valérie Mathieux
VUBIR (Vrije Universiteit Brussel)
November 1, 2016
Cited by 0
Related Papers
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
|Cold Spring Harbor Perspectives in Biology|2009|2.2k
American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
|Blood Advances|2020|1.4k
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
|Nature|2008|1.3k
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
|New England Journal of Medicine|2017|1.1k
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994